Home > Ag Rapid Test Kit >

Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency Clinical

Product Categories

Ag Rapid Test Kit [112]
COVID-19 Test Kit [88]
Coronavirus Neutralizing Antibody Rapid Test [42]
CRP Rapid Test Kit [70]
Sterile Surgical Packs [106]
Glycosylated Hemoglobin Test Kit [32]
Prolactin Test Kit [38]
Troponin I Rapid Test Kit [38]
Ferritin Rapid Test [8]
Dry Fluorescence Immunoassay Analyzer [24]
Blood Sample Collector [10]
Virus Sampling Tube [8]
NT-proBNP Test [6]
CK-MB Test Kit [8]
BNP Test Kit [8]
Heel Incision Device [14]
Venous Blood Collection Needle [14]
Blood Vacuum Container [34]
Disposable Protective Equipment [50]

Henan Lantian Medical Supplies Co.,Ltd.

Contact Now

Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency Clinical

Ask Lasest Price
Brand Name :	Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency Clinical
Model Number :	cTnl/MYO/CK-MB
Certification :	CE
Price :	To be negotiated
Supply Ability :	10000 Kit/Kit per Day
Delivery Time :	To be negotiated

Add to Cart

Product Details
Company Profile

Combined CTnI Myo CK-MB Rapid Test For Outpatient Emergency Clinical

CTnI/MYO/CK-MB Overview

The isoenzyme troponin I/myoglobin/creatine kinase (cTnI/Myo/CK-MB) includes the following three indicators: The combined detection of troponin I (cTnI), myoglobin (Myo) and creatine kinase isoenzyme (CK-MB) is of great importance for the Early diagnosis of acute myocardial diseases such as AMI

American Society for Clinical Biochemistry ( NACB ) Practice Guide

Signs of myocardial necrosis should be detected in all patients with ACS
Troponin is a key marker in the diagnosis of myocardial infarction
Myoglobin binding specific markers of myocardial necrosis (eg, cTnI/CK-MB) may help clear or diagnose myocardial infarction more quickly.

	MYO	CK-MB	cTnI
molecular weight	17.8KD	86KD	22.5KD
Rise time	1-2h	4-6h	3-6h
Peak time	6-9h	24h	12-16h
recovery time	18-30h	2-3d	4-10d
Clinical value	1. The most important AMI map was released in the first stage 2. Re-diagnose America and the best indication to evaluate the effect of re-treatment	1. Font size or re-launch 2. The most valuable mark of the highest non-ST part of MI	1. Preferential signs for diagnosing AMI 2. Judge the size of the gap and the risk strategy

cTnI/MYO/CK-MB Performance Index

Detection range			sample size	Sample type	Test time
cTnI	MYO	CK-MB	60μl	Whole blood / serum / plasma	15min
0.1~50ng/mL	10~200ng/mL	0.8~100ng/mL

CTnI/MYO/CK-MB Clinical Significance

This is for the initial and strategic diagnosis of corneal syndrome risk
Defining the area of myocardial infarction
Different diagnosis of different causes of chest pain
Beware of myocardial injury for a variety of reasons
Evaluation of clinical evidence of some medical drugs

Possibility of outcome
cTnI	CK-MB	MYO	Clinical possibility
+	+	+	Myocardial infarction / myocardial injury can basically be diagnosed and the time of onset is 12-24 hours.
+	+	-	It can basically be diagnosed as a myocardial infarction injury / myocardial infarction injury, and the detection time is more than one day that has passed during the myocardial identification window.
+	-	-	Myocardial damage occurs for a few days and should be rechecked in a few hours.
+	-	+	In patients with hepatic myocardial injury, symptoms may last for more than three days, and in patients with re-injury or necrotic areas due to blood clots.
-	+	+	In early myocardial ischemia, liver myocardial injury following monitoring of CTNI in 4-8 hours is recommended.
-	-	+	It is recommended to check CTNN in 4-8 hours.
-	-	+	The reserves can be caused by other diseases such as creative work, musculoskeletal injuries, and liver and kidney disease.
-	+	-	For minor myocardial injury, we recommend CT monitoring in 4-8 hours.
-	+	-	It may not be myocardial injury and the test time was through my window.
-	-	-	The possibility of ischemic myocardial injury is generally ruled out. When in doubt, it is recommended to check every two to four hours.

Application Department

Emergency outpatient departments, Cardiovascular Examination Centers, ICUs and Chest Pain Centers

CTnI/MYO/CK-MB Clinical Comparison

Company profile

Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.

Product Tags:


*From:	Your email address is incorrect!
*To:	Henan Lantian Medical Supplies Co.,Ltd.
*Subject:	Subject is empty!
*Message:	For the best results, we recommend including the following details: -Self introduction -Required specifications -Inquire about price/MOQ Characters Remaining: (0/3000) Please enter 20 to 3000 characters to contact this supplier!